Gencor Completes Successful Clinical Study On "Gencinia"

GENCINIA is a proprietary extract of the herb Coccinia Cordifolia developed by Gencor. In a double blind, randomized, placebo controlled clinical trial conducted on 60 patients with mild diabetes for a period of 90 days, Gencor's GENCINIA showed excellent results in controlling fasting and post prandial blood sugar and also in reducing glycosylated hemoglobin levels. All these three results were statistically significant.

The results of the study were published in the journal "Diabetes Care ". Gencor is working on seeking seeking suitable marketing partners for the product worldwide.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.